The present invention relates to pharmaceutical compositions containing one or more compounds of formula 1whereinR1 is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl；R2 is H, C1-6-alkyl；X is an anion selected from the group consisting of chloride or ½ dibenzoyltartrate；j is 1 or 2； andprocesses for the preparation thereof, and their use to treat diseases connected with the CCR3 receptor.
